Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
40771901	b-kml-qr	— (—)	193	1803	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Liquid cancers

139

82.94

249.72

12.6

1.0

—

Liquid cancers, including Hilmo

140

82.85

236.01

12.5

1.0

—

Primary_lymphoid and hematopoietic malignant neoplasms

110

41.12

182.37

15.6

1.0

—

Other diseases of blood and blood-forming organs, wide

34.27

134.19

9.8

8.6

—

Myeloproliferative diseases

126

261.55

123.85

13.4

1.0

—

Myeloid leukaemia

101

+∞

107.15

16.5

0.0

—

Chronic myeloid leukaemia, including Hilmo

+∞

106.94

17.0

0.0

—

Chronic myeloid leukaemia

+∞

84.02

17.6

0.0

—

L01XE Protein kinase inhibitors

155.74

71.48

19.6

1.0

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

105

9.20

70.86

9.1

10.0

—

Malignant neoplasm, including Hilmo

16.17

70.66

12.2

1.0

—

Malignant neoplasm

15.76

70.22

12.6

1.0

—

Malignant neoplasm

15.76

70.22

12.6

1.0

—

Malignant neoplasm, wide definition

15.48

68.60

12.4

1.0

—

Any event in cancer register

7.61

37.79

12.7

3.9

—

Neoplasms

12.41

35.50

13.1

1.0

—

L01XX Other antineoplastic agents

52.12

34.50

8.5

12.6

—

Other and unspecified diseases of blood and blood-forming organs

+∞

31.41

7.6

0.0

—

Other diseases of blood and blood-forming organs

46.79

30.61

7.2

13.4

—

Myeloproliferative diseases (CML excluded)

58.51

25.01

1.0

—

Any reimbursement code in KELA

9.69

17.00

13.2

1.0

—

Abnormal findings on examination of blood, without diagnosis

4.42

16.29

8.3

10.1

—

Other abnormal findings of blood chemistry

23.56

15.11

3.5

13.2

—

Solid cancers, including Hilmo

5.83

14.27

7.7

1.0

—

Lymphoid leukaemia

20.16

13.77

15.0

11.4

—

Leukaemia of unspecified cell type

+∞

13.63

13.8

0.0

—

Bacterial infection, other or unspecified

3.69

11.73

12.7

9.0

—

Bacterial infection, other or unspecified, including avohilmo

3.52

11.50

13.1

8.8

—

Gout

4.73

11.49

12.9

8.8

—

Solid cancers

5.13

11.16

7.9

1.0

—

Gout, FINNGEN

4.40

11.05

12.9

9.0

—

Other bacterial diseases

122

2.93

10.94

10.4

9.6

—

Malignant neoplasm of skin, including Hilmo

6.39

10.87

7.6

1.0

—

Examination and observation for other reasons

4.20

10.16

9.6

8.3

—

Heart failure, not strict

3.04

9.36

11.7

7.6

—

Pain, not elsewhere classified

4.23

8.64

11.8

8.5

—

Other special examinations and investigations of persons without complaint or reported diagnosis

3.77

8.58

8.8

8.3

—

Other heart diseases

4.12

8.58

11.9

8.6

—

Cardiovascular diseases (excluding rheumatic etc)

3.69

8.50

11.8

8.6

—

Chronic myeloproliferative disease

+∞

8.35

5.4

0.0

—

Eosinophilia

+∞

8.35

1.0

0.0

—

Other bacterial diseases, including avohilmo

124

2.57

8.09

10.3

9.1

—

All chronic kidney diseases

3.06

7.67

12.3

8.7

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

102

2.64

7.55

9.0

8.7

—

102

2.64

7.55

9.0

8.7

—

Medical observation and evaluation for suspected diseases and conditions

3.57

7.55

9.8

8.3

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

6.90

7.19

13.1

5.4

—

Codeine

2.64

7.11

9.4

9.3

—

Pneumonias (Asthma/COPD co-morbidities)

130

2.41

6.86

9.3

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

6.39

6.83

9.4

1.0

—

Malignant neoplasm of skin

6.09

6.62

7.9

1.0

—

All pneumoniae

133

2.34

6.47

9.3

9.5

—

Tramadol

2.66

6.44

10.5

9.3

—

Asthma (only as main-diagnosis), excluding more controls

3.07

6.33

5.9

9.1

—

Influenza and pneumonia

131

2.31

6.31

8.8

9.3

—

Any gastric operation

2.89

6.30

11.2

7.7

—

GASTRO-related operations

2.89

6.30

11.2

7.7

—

Basal cell carcinoma, including Hilmo

6.06

6.27

7.2

1.0

—

Heart failure and antihypertensive medication

6.14

6.26

10.9

6.5

—

COPD differential diagnosis

2.83

6.25

7.5

9.3

—

ILD differential diagnosis

2.83

6.25

7.5

9.3

—

Fever of other and unknown origin

2.92

6.21

14.2

8.6

—

Anaemias

14.10

6.21

6.6

1.0

—

General symptoms and signs

2.40

6.21

11.2

8.9

—

Dental caries

4.01

6.17

13.9

9.2

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

136

2.30

6.14

9.4

—

Other heart diseases, wide

108

2.41

6.05

10.1

9.2

—

Asthma, excluding more controls

2.95

5.99

6.4

9.1

—

Excluding asthma or asthma-COPD overlap

2.74

5.94

7.5

9.0

—

Other pulmonary diagnosis

2.74

5.94

7.5

9.0

—

All kidney diseases

135

2.28

5.93

10.3

8.8

—

Asthma (mode)

2.80

5.89

6.1

9.3

—

Provisional assignment of new diseases of uncertain etiology

100

2.78

5.87

8.7

9.8

—

Renal failure

2.88

5.82

11.7

9.3

—

Codes for special purposes

101

2.75

5.77

8.7

9.9

—

COPD/asthma related infections

102

2.31

5.74

8.5

8.7

—

COPD/asthma/ILD related infections

102

2.31

5.74

8.5

8.7

—

Covid-19 confirmed case

3.06

5.73

9.2

8.9

—

Hypothyroidism (congenital or acquired)

12.31

5.70

4.8

1.0

—

Renal tubulo-interstitial diseases

134

2.30

5.62

10.9

8.6

—

Pneumonia, organism unspecified

125

2.30

5.58

10.3

9.7

—

Diarrhoea and gastroenteritis of presumed infectious origin

123

2.47

5.56

12.0

8.1

—

Certain infectious and parasitic diseases

2.37

5.55

12.1

6.9

—

Statin medication

2.73

5.45

9.9

9.1

—

Basal cell carcinoma

5.68

5.37

8.0

1.0

—

Non-small cell lung cancer, including Hilmo

12.07

5.36

4.0

1.0

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

5.66

5.35

10.3

1.0

—

Atrial fibrillation and flutter

4.13

5.33

11.3

6.6

—

Bacterial pneumonia, not elsewhere classified

2.97

5.30

9.4

10.0

—

Hypertensive diseases (excluding secondary)

3.19

5.26

9.5

8.2

—

Asthma

2.66

5.25

6.2

9.3

—

Persons encountering health services for examination and investigation

3.03

5.24

7.9

8.3

—

Malaise and fatigue

2.72

5.22

8.2

8.3

—

Acute myeloid leukaemia and myelodysplastic syndromes

+∞

5.21

4.0

0.0

—

Asthma (only as main-diagnosis)

2.70

5.20

5.9

9.3

—

Cardiovascular diseases

3.11

5.13

12.7

8.0

—

Hypothyroidism and >3 levothyroxin purchases

11.21

5.04

5.2

1.0

—

Hypothyroidism, levothyroxine purchases

11.21

5.04

5.2

1.0

—

Malignant neoplasm of digestive organs, including Hilmo

5.42

4.96

6.9

1.0

—

Bacterial pneumoniae

2.84

4.94

9.4

10.1

—

Hypertension, essential

2.41

4.91

7.2

10.1

—

Heart failure,strict

2.71

4.83

10.5

7.9

—

Asthma, unspecified (mode), excluding more controls

2.97

4.83

7.0

9.1

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

3.33

4.77

9.4

7.5

—

Diabetes, varying definitions

120

2.13

4.71

8.5

9.9

—

Malignant neoplasm of bronchus and lung, including Hilmo

9.39

4.70

4.0

1.0

—

Acute bronchitis

2.72

4.68

11.3

9.6

—

Depression medications

10.05

4.68

10.1

1.0

—

Diabetes mellitus

120

2.12

4.66

8.5

9.9

—

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

9.25

4.65

4.0

1.0

—

Other and unspecified anaemias

2.65

4.62

10.1

8.2

—

Other anaemias

2.64

4.59

10.1

8.2

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

2.45

4.57

9.4

9.2

—

Diseases of liver

2.80

4.54

8.4

9.1

—

Aplastic and other anaemias

2.57

4.51

9.8

8.3

—

Codeine or tramadol medication

129

2.02

4.46

9.9

9.1

—

Opioids

2.21

4.46

9.7

9.4

—

Infections, IBD-co-morbidities

5.63

4.41

17.0

9.3

—

Diseases of the respiratory system

2.60

4.40

8.3

8.4

—

Oxycodone

2.81

4.40

9.4

7.9

—

Atherosclerosis, excluding cerebral and coronary sclerosis

2.70

4.40

14.0

7.7

—

Asthma, unspecified (mode)

2.72

4.37

6.7

9.2

—

Other septicaemia

2.82

4.31

10.1

9.3

—

Septicaemia

2.74

4.27

9.6

9.4

—

Type 2 diabetes

118

2.06

4.19

7.4

10.0

—

Diseases of oesophagus, stomach and duodenum

137

1.98

4.17

10.8

9.0

—

Neurotic, stress-related and somatoform disorders

129

2.08

4.17

11.1

8.6

—

Other septicaemia, including avohilmo

2.76

4.17

10.1

9.1

—

Anxiety disorders

129

2.07

4.13

11.1

8.6

—

Caries of dentine

3.81

4.12

15.6

8.9

—

Hypertensive diseases

2.27

4.12

7.5

10.1

—

Hypertension

2.27

4.12

7.5

10.1

—

Type 2 diabetes, definitions combined, including avohilmo

115

2.06

4.10

7.2

9.9

—

Complications of medical and surgical care

143

2.14

4.10

10.4

8.9

—

Insulin medication

105

2.29

4.06

8.8

10.6

—

Other medical care

2.40

4.03

6.3

8.7

—

Other soft tissue disorders, not elsewhere classified

114

2.05

4.02

12.9

8.3

—

Type 2 diabetes, strict (exclude DM1)

117

2.04

4.01

7.1

9.9

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

133

2.21

4.01

10.3

8.7

—

Type 2 diabetes, definitions combined

117

2.04

4.01

7.1

9.9

—

Benign neoplasms

109

2.05

3.98

10.3

8.5

—

Unspecified kidney failure

5.56

3.97

10.9

12.8

—

Use of hypnotics and sedatives

135

1.95

3.96

12.6

8.7

—

Parasetamol

2.28

3.92

9.6

11.4

—

Bronchitis

143

1.93

3.91

11.9

8.2

—

Bacterial pneumonia (organism specified)

2.48

3.89

9.4

9.3

—

Anxiety disorders, excluding more controls

110

2.09

3.85

10.7

8.7

—

Other acute lower respiratory infections

101

2.36

3.85

10.4

10.0

—

Insulin, combination of fast acting with intermediate-acting or long-acting

119

2.21

3.82

8.8

10.2

—

Pain in limb

114

2.06

3.82

13.5

8.3

—

Chronic lower respiratory diseases

137

1.88

3.78

7.2

10.3

—

Injuries to the hip and thigh

2.39

3.77

10.5

9.0

—

Cerebrovascular diseases (FINNGEN)

3.38

3.75

11.1

6.4

—

Personality disorders, excluding more controls

3.18

3.75

6.6

9.3

—

Cardiac arrhythmias

2.38

3.74

8.3

9.1

—

Visual disturbances

102

2.35

3.72

10.3

9.0

—

Endocrine, nutritional and metabolic diseases

2.19

3.72

8.9

10.9

—

Persons encountering health services for specific procedures and health care

135

1.92

3.71

10.7

9.2

—

Any death

100

2.17

3.71

7.5

9.4

—

Polyarthropathies

2.16

3.63

11.8

8.6

—

ILD medications: prednisolone, methylprednisolone, prednisone

128

1.91

3.60

7.0

10.1

—

Coagulation defects, purpura and other haemorrhagic conditions

3.50

3.59

5.8

8.2

—

Unspecified privation

4.77

3.55

5.1

11.6

—

124

1.88

3.52

10.5

8.4

—

Type 2 diabetes, wide definition

100

2.08

3.50

7.6

9.0

—

Malignant neoplasm of digestive organs

4.43

3.48

5.5

1.0

—

Atrial fibrillation and flutter with reimbursement

4.20

3.47

8.5

5.9

—

Intestinal infectious diseases

151

1.92

3.47

13.3

8.3

—

Malignant neoplasm of bladder, including Hilmo

9.88

3.46

7.3

1.0

—

Diabetes medication

129

1.90

3.45

7.5

10.2

—

Oedema, not elsewhere classified

2.68

3.42

7.9

7.7

—

Malignant neoplasm of bronchus and lung

7.32

3.33

2.0

1.0

—

Malignant neoplasm of respiratory system and intrathoracic organs

7.26

3.31

2.0

1.0

—

Finngen Rheumatological endpoints

119

1.91

3.30

9.0

9.5

—

Generalized anxiety disorder

4.34

3.30

7.7

10.8

—

Visual disturbances and blindness

108

2.22

3.29

10.3

9.0

—

Nonorganic sleeping disorders, excluding more controls

3.64

3.28

10.3

8.2

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

3.93

3.28

5.0

9.1

—

Other metabolic disorders

3.93

3.28

5.0

9.1

—

Non-Hodgkin lymphoma, all, including Hilmo

8.58

3.26

8.7

1.0

—

Certain infectious and parasitic diseases, including avohilmo

2.15

3.26

9.1

7.7

—

Biguanides

128

1.89

3.25

6.4

10.0

—

Specific personality disorders

3.03

3.24

7.0

10.3

—

Arthropathies

1.97

3.24

10.6

8.5

—

Diseases of the eye and adnexa

2.08

3.23

12.3

8.4

—

Anxiety (asthma-related co-morbidities)

2.17

3.22

11.5

9.3

—

Other reaction to severe stress, and adjustment disorders

2.57

3.20

14.5

8.6

—

Acute renal failure

2.96

3.13

10.4

9.6

—

Iron deficiency anaemia

2.29

3.09

6.7

8.9

—

Insulin, intermediate and long-acting

114

2.12

3.06

9.2

10.0

—

Fall on and from stairs and steps

2.68

3.05

9.7

7.6

—

Fibrosis and cirrhosis of liver

5.01

3.05

4.0

11.9

—

All-cause Heart Failure

2.13

3.02

10.5

9.1

—

Heart failure, strict

2.13

3.02

10.5

9.1

—

Other and unspecified coagulation defects

10.02

2.98

1.0

7.6

—

Malignant neoplasm of endocrine gland, including Hilmo

10.01

2.98

11.2

1.0

—

Diseases of oral cavity, salivary glands and jaws

2.22

2.98

11.1

8.5

—

Purpura and other haemorrhagic conditions

3.85

2.97

7.7

9.8

—

malignant neoplasm of female genital organs, including Hilmo

7.15

2.95

4.8

1.0

—

All anxiety disorders

2.08

2.93

11.5

9.4

—

Personality disorders

2.69

2.88

6.6

11.0

—

Biomechanical lesions, not elsewhere classified

6.68

2.87

12.5

9.3

—

Nutritional anaemias

103

2.13

2.86

7.2

8.8

—

Other specific joint derangements/joint disorders

2.01

2.86

11.4

8.6

—

Metabolic disorders

129

1.81

2.85

9.6

10.0

—

Other anxiety disorders

2.27

2.83

11.0

8.7

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

5.22

2.79

6.6

1.0

—

Non-ischemic cardiomyopathy

2.59

2.73

11.7

5.9

—

Secondary hypertension

8.21

2.72

16.4

8.0

—

Excessive attrition of teeth

130

1.98

2.71

8.4

9.6

—

ILD medications

129

1.75

2.71

7.3

10.0

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

117

1.82

2.69

7.9

9.9

—

Diseases of arteries, arterioles and capillaries

110

1.93

2.69

12.5

8.2

—

Diabetes, insulin treatment (Kela reimbursement)

135

1.76

2.69

9.0

9.9

—

Peripheral artery disease

2.22

2.68

15.1

7.9

—

Explicit Sepsis

2.15

2.67

9.6

8.5

—

Hyperplasia of prostate

2.41

2.64

9.8

11.3

—

Explicit Sepsis, including avohilmo

2.14

2.64

9.6

8.5

—

Malignant neoplasm of breast, HER2-negative

3.58

2.61

11.7

1.0

—

Malignant neoplasm of breast

3.58

2.61

11.7

1.0

—

Other diseases of anus and rectum

2.45

2.59

12.7

7.7

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

3.56

2.59

11.7

1.0

—

Malignant neoplasm of breast, including Hilmo

3.56

2.59

11.7

1.0

—

Other (not insulin) diabetes medications

126

1.77

2.59

5.9

10.1

—

Gingivitis and periodontal diseases

110

1.78

2.58

8.9

—

Malignant neoplasm of breast, HER-positive

4.26

2.58

11.4

1.0

—

Malignant neoplasm of breast, ER-positive, including Hilmo

4.25

2.57

11.4

1.0

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.00

2.56

14.8

11.4

—

Chronic periodontitis, including avohilmo

143

1.74

2.56

8.9

9.6

—

Non-rheumatic valve diseases

2.20

2.55

12.1

7.9

—

Periodontitis

143

1.74

2.55

8.9

9.6

—

Primary biliary cholangitis (PBC)

7.18

2.55

4.4

12.1

—

Nonorganic sleeping disorders

2.73

2.54

10.3

10.2

—

Oral corticosteroids

140

1.72

2.53

8.0

9.8

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

128

1.95

2.52

10.3

8.6

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.23

2.51

7.7

10.3

—

Other diseases of intestine

3.23

2.51

8.9

7.6

—

Complications of surgical and medical care, not elsewhere classified

151

1.72

2.51

10.3

9.1

—

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

145

1.72

2.50

11.9

8.4

—

Valvular heart disease excluding rheumatic fever

2.16

2.48

12.1

7.8

—

Other and unspecified visual disturbances

3.81

2.46

6.6

11.5

—

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

156

1.75

2.43

10.3

9.1

—

Pain in joint

2.02

2.43

10.9

8.8

—

Other inflammation of eyelid

3.13

2.43

5.9

8.5

—

L04AC Interleukin inhibitors

5.01

2.40

7.3

11.3

—

Coxarthrosis

2.03

2.40

7.3

7.7

—

Any mental disorder

121

1.70

2.36

10.4

8.7

—

Implicit viral Sepsis

2.61

2.35

18.9

7.5

—

Viral Sepsis

2.61

2.35

18.9

7.5

—

Other and unspecified dermatitis

111

1.98

2.34

9.5

8.9

—

malignant neoplasm of female genital organs

6.12

2.33

5.6

1.0

—

Acute tubulo-interstitial nephritis

111

1.90

2.31

9.4

8.2

—

ILD medications: immunosuppressive drugs

120

1.89

2.29

7.8

10.4

—

Symptoms and signs involving the skin and subcutaneous tissue

153

1.79

2.27

9.7

9.1

—

Conductive hearing loss, unspecified

4.62

2.27

5.3

16.5

—

Coxarthrosis [arthrosis of hip](FG)

1.94

2.27

7.0

8.3

—

Suggestive for eosinophilic asthma

3.48

2.27

1.0

10.4

—

Poisoning by drugs, medicaments and biological substances

2.55

2.26

7.8

9.1

—

Implicit bacterial Sepsis

2.09

2.26

14.2

8.6

—

Implicit viral Sepsis, including avohilmo

2.27

2.22

15.3

8.2

—

Superficial injury of hip and thigh

3.10

2.22

11.3

9.1

—

Malignant melanoma of skin, including Hilmo

5.56

2.21

1.2

1.0

—

Intestinal infectious diseases, including avohilmo, including avohilmo

143

1.63

2.19

12.4

8.5

—

Lower back pain or/and sciatica

151

1.65

2.19

9.9

9.2

—

Asthma (diagnoses ohter than nonallergic)

156

1.71

2.17

5.8

10.0

—

Continuous positive airway pressure

2.87

2.17

19.1

6.8

—

Pain in throat and chest

108

1.75

2.17

11.7

10.6

—

Hernia of abdominal wall, postoperative

3.31

2.16

4.4

6.3

—

Bacterial Sepsis

1.97

2.15

13.8

8.6

—

Asthma, hospital admissions , main diagnosis only

156

1.73

2.15

5.8

9.9

—

Other specified and unspecified personality disorders

4.29

2.15

7.5

9.3

—

Acute upper respiratory infections of multiple and unspecified sites

119

1.78

2.14

13.7

8.6

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

133

1.64

2.14

9.3

9.8

—

Gout, unspecified

2.62

2.14

11.1

9.5

—

Other external causes of accidental injury

1.76

2.12

7.6

8.6

—

First line medication for Crohn's disease

131

1.64

2.12

8.5

9.6

—

All influenza

2.45

2.10

12.3

10.3

—

Other diseases of intestines

128

1.65

2.08

12.2

9.1

—

Poisoning by medicine

2.56

2.07

8.5

8.8

—

Lesion of lateral popliteal nerve

5.01

2.07

14.8

7.6

—

Agranulocytosis

5.00

2.07

13.0

10.9

—

Malignant melanoma, including Hilmo

5.00

2.07

1.2

1.0

—

Fall on same level involving ice and snow

124

1.85

2.05

10.4

9.4

—

Nonalcoholic fatty liver disease

3.50

2.05

7.3

10.8

—

Pure hypercholesterolaemia

109

1.75

2.05

9.8

9.5

—

Viral pneumonia

3.50

2.05

10.3

9.3

—

Asthma, hospital admission 2, infections

121

1.85

2.04

5.7

10.4

—

Asthma-related infections

121

1.85

2.04

5.7

10.4

—

Disorders of adult personality and behaviour

2.32

2.04

7.0

11.3

—

Other and/or unspecified nontoxic goitre

4.00

2.04

3.0

8.5

—

Persons encountering health services for specific procedures, not carried out

4.00

2.04

14.5

13.5

—

Follow-up examination after treatment for conditions other than malignant neoplasms

2.33

2.04

9.9

7.8

—

Spondylosis

102

1.84

2.01

9.0

8.4

—

Transplanted organ and tissue status

3.08

2.01

12.6

9.5

—

Disorders of lipoprotein metabolism and other lipidaemias

114

1.71

2.01

9.3

9.4

—

Allergic asthma (mode), excluding more controls

2.83

2.01

3.8

9.5

—

Nerve, nerve root and plexus disorders

145

1.61

2.00

11.7

9.1

—

Inflammatory bowel disease treatment related agents

142

1.60

2.00

8.6

9.7

—

External causes of morbidity and mortality

1.87

2.00

7.9

8.6

—

Chronic sinusitis

2.00

1.99

9.2

10.2

—

Exposure to unspecified factor

155

1.62

1.98

11.0

8.9

—

Urinary track infection

1.98

1.97

11.5

7.2

—

Lung cancer and mesothelioma

2.83

1.97

4.0

9.9

—

Abnormal weight loss

3.34

1.96

1.0

10.7

—

Other pleural conditions

3.34

1.96

12.6

9.2

—

Symptoms and signs concerning food and fluid intake

3.33

1.96

1.0

7.7

—

Diseases of male genital organs

2.01

1.96

9.7

12.5

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

2.47

1.95

7.1

7.8

—

Other diseases of liver

2.57

1.94

7.2

7.9

—

Undetermined asthma

3.75

1.93

1.0

9.4

—

Undetermined asthma, excluding more controls

3.75

1.93

1.0

8.4

—

Acute pharyngitis

2.93

1.91

4.9

10.9

—

Other and unspecified iron deficiency

2.05

1.89

8.5

8.8

—

Accidents

1.71

1.88

7.8

8.6

—

Weight loss

3.19

1.88

1.0

10.3

—

Erysipelas

1.89

1.87

7.1

9.4

—

Chronic gastritis

2.31

1.87

11.1

8.0

—

Other viral diseases, including avohilmo

2.09

1.87

9.7

10.7

—

Allergic asthma (mode)

2.66

1.87

3.8

9.9

—

Cystitis

105

1.70

1.86

10.2

8.6

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

3.82

1.86

11.3

8.3

—

1.94

1.85

5.4

11.0

—

Dental operations

1.81

1.85

10.2

9.2

—

Paroxysmal tachycardia

2.89

1.84

8.9

6.2

—

Other coagulation defects

4.17

1.82

1.0

10.3

—

Used for control exclusion in common control thyroid runs

116

1.61

1.82

9.5

10.1

—

Ocular pain

4.17

1.82

23.2

8.8

—

Other viral diseases

2.20

1.82

11.0

10.0

—

Coxarthrosis, primary

113

1.76

1.81

7.4

8.7

—

Complications of procedures, not elsewhere classified

146

1.65

1.81

10.4

9.0

—

Other specified/unspecified arthritis

2.27

1.80

7.2

7.9

—

Autoimmune diseases excluding thyroid diseases

130

1.58

1.79

9.8

9.9

—

Diseases of pulp and periapical tissues, including avohilmo

120

1.59

1.78

10.1

9.5

—

Falls/tendency to fall

120

1.59

1.78

10.5

9.0

—

General examination and investigation of persons without complaint and reported diagnosis

2.05

1.77

12.8

8.3

—

Autoimmune diseases

130

1.56

1.76

9.5

9.9

—

Chronic kidney disease

2.16

1.74

13.2

9.2

—

Myocardial infarction, without ST-elevation

1.94

1.73

10.4

9.1

—

Subjective visual disturbances

2.22

1.73

9.7

8.0

—

Asthma-related pneumonia

2.02

1.73

4.7

9.5

—

Asthma, hospital admissions 3, pneumonia

2.02

1.73

4.7

9.5

—

Asthma-related pneumonia or sepsis

2.02

1.73

4.7

9.5

—

2.92

1.72

7.9

11.5

—

Thrombocytopenia, unspecified

3.85

1.71

11.4

11.6

—

Persons encountering health services in other circumstances, wide

133

1.55

1.70

10.3

9.8

—

Zoster [herpes zoster], including avohilmo

114

1.78

1.68

7.9

8.2

—

Arthrosis

1.70

1.68

8.1

8.3

—

Asthma, including avohilmo

148

1.52

1.68

5.9

10.4

—

COPD (mode)

2.32

1.66

8.2

9.4

—

Gout, strict definition

2.50

1.66

11.5

9.8

—

Emotionally unstable personality disorder

3.16

1.66

3.0

11.3

—

Implicit bacterial Sepsis, including avohilmo

1.84

1.64

14.2

8.5

—

Benzodiazepine use

157

1.55

1.64

7.6

9.8

—

Pain (limb, back, neck, head abdominally)

1.71

1.63

8.2

8.9

—

Chronic periodontitis, complicated

124

1.73

1.61

8.6

8.9

—

Other and unspecified injuries of lower leg

3.57

1.61

17.2

11.9

—

Autoimmune diseases related-to ILD

157

1.59

1.61

8.0

9.7

—

Disorders of vitreous body

114

1.75

1.61

7.3

8.7

—

Heart failure and bmi 25plus

2.07

1.60

7.9

9.3

—

Hard cardiovascular diseases

114

1.61

1.60

9.5

8.2

—

Colorectal cancer, including Hilmo

3.58

1.60

6.8

1.0

—

Other disorders of urethra and urinary system

103

1.69

1.60

12.5

8.4

—

Mood disorders, excluding more controls

118

1.59

1.60

9.5

8.6

—

Persistent mood disorders

2.50

1.59

5.9

8.8

—

Early onset COPD, excluding more controls

2.50

1.59

11.1

10.6

—

Iron deficiency anaemia secondary to blood loss (chronic)

2.69

1.58

3.6

8.7

—

Cough

1.87

1.58

6.6

10.2

—

Soft tissue disorders

115

1.56

11.7

8.4

—

Fracture of femur

2.12

1.54

8.1

8.4

—

Antihypertensive medication - note that there are other indications

1.93

1.54

11.7

10.4

—

Acute upper respiratory infections

141

1.53

1.54

11.4

8.2

—

Fall on same level

142

1.50

1.54

9.5

9.6

—

Benign neoplasm of ovary

2.43

1.53

7.0

8.6

—

Malignant neoplasm of prostate

3.70

1.53

8.0

1.0

—

Gastro-oesophageal reflux disease

128

1.65

1.53

12.2

8.5

—

Malignant neoplasm of prostate, including Hilmo

3.69

1.52

8.0

1.0

—

Cyst of kidney

3.34

1.52

2.2

9.9

—

Diseases of middle ear and mastoid

1.73

1.52

7.3

10.8

—

Other disorders of skin and subcutaneous tissue

135

1.62

1.51

8.4

9.4

—

Gout, idiopatic and unspecified

2.16

1.50

11.1

10.1

—

Suicide or other Intentional self-harm

2.16

1.50

7.1

8.0

—

Dental caries, including avohilmo

1.66

1.50

8.8

9.5

—

Disorders of tooth development and eruption

2.87

1.47

16.0

8.2

—

Disorders of vitreous body and globe

117

1.70

1.46

7.3

8.8

—

Diseases of pulp and periapical tissues and dental caries

1.71

1.46

9.6

—

Headache

1.74

1.45

9.6

8.1

—

Caries of enamel

141

1.53

1.45

7.9

9.8

—

Low back pain

119

1.59

1.44

9.3

—

Other disorders of nervous system

3.13

1.44

21.6

11.6

—

Pneumonitis due to solids and liquids

3.13

1.44

8.6

8.7

—

Condition for Implicit Sepsis (Organ dysfunction codes)

128

1.57

1.43

12.7

9.3

—

L04AD Calcineurin inhibitors

2.73

1.43

10.3

10.5

—

Dermatitis

137

1.64

1.43

9.6

9.3

—

Other inflammation of eyelid, including avohilmo

1.79

1.42

6.4

9.7

—

Asthma and allergy, excluding more controls

3.09

1.42

6.0

10.8

—

malignant neoplasm of male genital organs

3.34

1.42

8.0

1.0

—

malignant neoplasm of male genital organs, including Hilmo

3.34

1.41

8.0

1.0

—

Neurological diseases, wide definition

2.38

1.41

12.3

9.5

—

Other or unspecified ileus, impaction or obstruction

2.25

1.40

11.9

7.8

—

Phlebitis and thrombophlebitis (not including DVT)

2.17

1.39

10.1

7.4

—

Depression or dysthymia

1.67

1.39

11.1

9.5

—

Implicit Sepsis

126

1.58

1.39

12.9

8.9

—

Other arthritis (FG)

2.00

1.37

7.2

8.0

—

Other embolism and thrombosis

2.61

1.36

15.3

9.0

—

Abdominal and pelvic pain

117

1.50

1.36

13.0

8.6

—

Flat foot [pes planus] (acquired)

2.94

1.36

16.4

8.4

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

2.25

1.35

13.4

9.7

—

Chondropathies

0.00

1.34

0.0

9.9

—

COPD

1.77

1.34

9.4

9.9

—

Asthma and allergy

2.90

1.34

6.0

11.9

—

Depression

142

1.51

1.34

10.1

9.3

—

Viral infections characterized by skin and mucous membrane lesions

1.78

1.32

14.8

8.8

—

Otitis media, unspecified

2.88

1.32

6.4

13.4

—

Diseases of the skin and subcutaneous tissue

110

1.50

1.30

11.3

9.6

—

Coxibs

2.14

1.29

7.4

11.7

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1.84

1.29

4.9

8.5

—

Psychiatric diseases

106

1.51

1.29

9.5

9.2

—

Hypertensive heart and/or renal disease

2.15

1.29

16.4

9.6

—

Acute sinusitis

1.70

1.28

8.9

8.5

—

Problems related to lifestyle

2.78

1.28

5.0

12.7

—

Other joint disorders

1.55

1.28

11.8

8.5

—

Diseases of the ear and mastoid process

131

1.45

1.28

7.9

9.7

—

Dermatitis and eczema

151

1.45

1.27

10.2

9.3

—

Nontoxic goitre/thyroid nodule

1.94

1.27

8.1

—

Autoimmune diseases excluding thyroid diseases, strict definition

125

1.48

1.27

10.3

10.0

—

Implicit Sepsis, including avohilmo

131

1.53

1.26

12.5

9.2

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

141

1.48

1.26

10.2

9.2

—

Injuries to the thorax

1.72

1.26

10.2

9.5

—

Noninfective enteritis and colitis

1.72

1.26

10.5

9.7

—

Disorders of eyelid, lacrimal system and orbit

147

1.49

1.24

9.1

9.2

—

All influenza (not pneumonia)

2.40

1.24

10.0

12.8

—

Spinal stenosis

1.63

1.24

12.4

7.9

—

Spondylopathies

113

1.52

1.24

10.9

9.1

—

Other dorsopathies, not elsewhere classified

120

1.47

1.23

9.0

9.3

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

1.73

1.23

10.2

9.7

—

Other and unspecified effects of external causes

1.96

1.21

13.7

9.2

—

Cerebral palsy and other paralytic syndromes

2.63

1.21

17.4

12.7

—

Amputation

2.63

1.21

7.4

7.8

—

Other diseases of hard tissues of teeth

1.70

1.21

7.4

8.5

—

Bell's palsy

2.31

1.18

13.0

8.2

—

Unspecified acute lower respiratory infection

2.31

1.18

4.0

10.2

—

Other chronic obstructive pulmonary disease

1.72

1.18

9.9

10.1

—

Soft tissue disorders related to use, overuse and pressure

1.88

1.17

10.8

7.5

—

Symptoms and signs involving the digestive system and abdomen

117

1.46

1.17

12.4

8.6

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1.93

1.16

7.1

9.2

—

Mood [affective] disorders

146

1.45

1.16

9.8

9.4

—

Substance abuse, excluding more controls

1.65

1.15

10.2

9.8

—

Mood disorders

146

1.44

1.15

9.8

9.4

—

Dizziness and giddiness

134

1.51

1.15

7.3

9.6

—

Abscess of anal and rectal regions

2.50

1.15

13.4

8.2

—

Overexertion and strenuous or repetitive movements

2.50

1.15

17.4

11.1

—

Hydronephrosis

2.50

1.15

14.0

11.0

—

Localized swelling, mass and lump of skin and subcutaneous tissue

1.81

1.14

10.4

8.4

—

Obesity, other/unspecified

1.81

1.14

5.2

10.0

—

Special screening examination for infectious and parasitic diseases

2.43

1.14

4.9

12.6

—

Obesity

126

1.57

1.13

5.3

9.8

—

Obesity and other hyperalimentation

126

1.57

1.12

5.3

9.8

—

Insulin, fast-acting

1.75

1.12

10.4

10.0

—

Benign neoplasm of other and unspecified endocrine glands

2.33

1.12

10.4

9.3

—

Other disorders of the musculoskeletal system and connective tissue

2.33

1.12

11.7

9.8

—

Ulcer of lower limb, not elsewhere classified

2.33

1.12

9.1

8.4

—

Gastric ulcer

2.33

1.12

10.9

7.6

—

Pleural effusion

2.00

1.12

10.3

9.4

—

Nasal polyp

2.00

1.12

1.0

9.5

—

STROKE

1.60

1.11

11.2

7.0

—

Injuries to the knee and lower leg

151

1.40

1.11

9.4

9.3

—

Artrosis, including avohilmo

112

1.47

1.10

8.0

9.9

—

Factors influencing health status and contact with health services

2.15

1.10

8.3

10.7

—

Benign neoplasm: Adrenal gland

2.38

1.09

12.2

11.6

—

Other chronic obstructive pulmonary disease, including avohilmo

104

1.58

1.09

8.1

9.5

—

Periapical abscess

104

1.64

1.09

7.8

10.1

—

Benign neoplasm of other and ill-defined parts of digestive system

1.95

1.08

11.9

8.1

—

Other disorders of ear

139

1.44

1.08

7.4

9.7

—

Symptoms and signs involving the nervous and musculoskeletal systems

140

0.50

1.08

8.6

9.0

—

Coxarthrosis, primary, with hip surgery

104

1.60

1.07

8.4

8.9

—

Other neurological diseases

130

1.49

1.06

13.6

8.3

—

Abnormalities of breathing

109

1.47

1.05

6.4

10.5

—

Myocardial infarction

1.61

1.04

10.6

8.0

—

Panic disorder

2.27

1.03

11.4

11.3

—

Erysipelas, including avohilmo

113

1.51

1.03

7.2

9.5

—

Adjustment and management of implanted device

2.06

1.02

12.3

8.6

—

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

136

1.44

1.02

12.7

9.3

—

Gastroduodenal ulcer

1.91

1.01

8.7

7.9

—

Other diseases of pleura

1.64

1.01

9.4

9.6

—

Non-selective monoamine reuptake inhibitors

1.68

0.99

10.8

7.3

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

1.84

0.98

11.9

6.8

—

Disorders of other endocrine glands

1.64

0.98

7.7

9.6

—

Conductive and sensorineural hearing loss

124

1.44

0.98

7.3

9.0

—

LSIL lesion of the cervix uteri, vagina or vulva

0.00

0.97

0.0

8.8

—

Later onset COPD, excluding more controls

1.98

0.97

7.7

9.9

—

Trochanteric bursitis

1.95

0.97

7.9

7.1

—

Diverticular disease of intestine

101

1.48

0.96

10.8

8.6

—

Dementia in Alzheimer disease

0.00

0.96

0.0

9.8

—

L04AA Selective immunosuppressants

1.80

0.96

9.2

7.4

—

Abnormal involuntary movements

0.00

0.96

0.0

8.8

—

Asthma/COPD (KELA code 203)

137

1.41

0.95

6.9

10.3

—

Other diseases of upper respiratory tract

128

1.38

0.94

8.7

9.6

—

Fracture of foot, except ankle

1.77

0.94

8.2

9.4

—

Zoster [herpes zoster]

1.89

0.94

12.1

6.6

—

Abnormal findings on diagnostic imaging of lung

103

1.56

0.93

11.9

8.8

—

Fracture of rib(s), sternum and thoracic spine

1.71

0.92

11.3

9.1

—

Coronary artery bypass grafting

1.85

0.92

11.5

8.2

—

Disorders of gallbladder, biliary tract and pancreas

144

1.38

0.92

9.9

9.1

—

Calcific aortic valvular stenosis

1.76

0.92

15.2

8.2

—

Calcific aortic valvular stenosis, operated

1.76

0.92

15.2

8.2

—

Calcific aortic valvular stenosis, diagnosis (helper)

1.76

0.92

15.2

8.2

—

Operations 2 for CAVS

1.76

0.92

15.2

8.2

—

Strabismus

1.73

0.92

8.3

8.4

—

Calcific aortic valvular stenosis, including rheumatic fever

1.76

0.91

15.2

8.2

—

Other disorders of kidney and ureter

2.14

0.91

6.5

10.2

—

Insulin, fast-acting (human)

2.14

0.91

16.5

9.8

—

Budesonide

2.14

0.91

13.8

9.7

—

Venous thromboembolism

121

1.51

0.91

10.6

8.6

—

Allergic conjunctivitis

121

1.51

0.91

9.8

8.4

—

Insulin, fast-acting or short human

1.63

0.90

10.4

10.2

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

147

1.38

0.90

9.9

9.4

—

Rheumatism, unspecified

2.07

0.89

4.7

7.8

—

Benign leiomyoma with endometriosis

2.07

0.89

10.5

9.0

—

Enlarged lymph nodes

2.07

0.89

6.7

8.0

—

Other symptoms and signs involving the nervous and musculoskeletal systems

101

0.49

0.89

6.8

9.2

—

Other nutritional deficiencies

138

1.46

0.88

5.1

9.8

—

Intestinal stricture

1.69

0.88

11.8

8.7

—

Injury, poisoning and certain other consequences of external causes

1.60

0.87

9.8

9.2

—

Ischemic heart diseases

114

1.41

0.87

11.7

7.7

—

Inflammatory disease of uterus

2.00

0.87

5.5

9.5

—

Candidiasis

2.00

0.87

16.0

8.7

—

Other diseases of urinary system

117

1.39

0.86

11.5

8.9

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1.86

0.86

8.0

10.9

—

Adverse effects, not elsewhere classified

1.82

0.85

13.1

8.4

—

Nausea and vomiting

1.77

0.85

10.1

6.6

—

Sciatica+with lumbago

106

1.50

0.84

10.6

9.1

—

Dorsalgia

120

1.37

0.83

9.0

9.3

—

Postpartum hemorraghe, parous women as controls

1.93

0.83

7.7

7.8

—

Stroke, excluding SAH

104

1.46

0.83

10.7

8.3

—

Myocardial infarction, strict

1.55

0.83

10.4

8.2

—

Psoriasis vulgaris

1.74

0.82

6.1

8.5

—

Substance use, excluding alcohol

1.74

0.82

14.1

9.3

—

Candidiasis, including avohilmo

1.69

0.82

12.2

8.8

—

Diseases of the musculoskeletal system and connective tissue

1.57

0.82

8.6

8.9

—

Other disorders of eye and adnexa

1.88

0.81

19.5

9.4

—

Somatoform disorder

1.88

0.81

9.3

8.3

—

Lung diseases due to external agents

1.88

0.81

7.3

9.8

—

Heart failure and coronary heart disease

1.57

0.81

8.9

8.2

—

Spontaneous abortion

0.51

0.80

1.0

8.3

—

Syncope and collapse

1.58

0.80

10.9

8.7

—

Inflammatory diseases of female pelvic organs

1.48

0.80

5.4

8.0

—

Dorsopathies

120

1.35

0.80

9.5

9.3

—

DVT of lower extremities and pulmonary embolism

1.57

0.79

11.9

8.7

—

Achilles tendinitis

0.00

0.79

0.0

9.1

—

Other condition

1.82

0.79

17.0

8.9

—

Other/unspecified rheumatoid arthritis

0.00

0.79

0.0

9.2

—

Exposure to other specified factors

155

1.38

0.78

13.7

8.8

—

Injuries to the elbow and forearm

133

1.42

0.78

7.6

10.1

—

Recurrent or chronic depression

1.61

0.78

13.6

9.6

—

Exclusions for E4_PCOS_CONSORTIUM

1.44

0.77

10.4

8.1

—

Irregular menses

1.54

0.77

8.2

8.3

—

Abnormal spermatozoa

0.00

0.77

0.0

8.9

—

Benign thyroid growths and nodules

1.62

0.76

8.1

9.1

—

Ischaemic heart disease, wide definition

111

1.39

0.76

12.6

7.9

—

Combinations of oral blood glucose lowering drugs

1.70

0.75

7.8

9.6

—

Suppurative and unspecified otitis media

1.61

0.75

7.8

10.8

—

Diaphragmatic hernia

1.60

0.74

9.6

9.0

—

Other symptoms and signs involving the urinary system

2.08

0.74

10.2

9.9

—

Heartburn

2.08

0.74

11.8

6.7

—

Peripheral artery operations in Hilmo

2.08

0.74

11.2

7.9

—

Fissure and fistula of anal and rectal regions

1.67

0.74

20.0

7.6

—

Paralytic ileus and intestinal obstruction

1.67

0.74

11.9

7.9

—

COPD, early/later onset

1.49

0.73

9.9

9.6

—

Other respiratory diseases principally affecting the interstitium

1.84

0.73

9.9

9.3

—

Diabetic nephropathy, excluding more controls

2.04

0.73

15.8

7.2

—

Dysphagia

1.64

0.73

8.2

6.9

—

Other noninfective gastroenteritis and colitis

1.64

0.73

10.1

8.3

—

Dislocation, sprain and strain of joints and ligaments of knee

120

1.43

0.73

12.6

10.0

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

1.50

0.72

11.9

9.2

—

Other mental disorders due to brain damage and dysfunction and to physical disease

2.00

0.72

9.6

10.6

—

Hypokalaemia

2.00

0.72

13.0

8.7

—

DVT of lower extremities

1.80

0.72

17.4

8.0

—

Other skin changes

1.80

0.72

7.4

8.5

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

133

0.66

0.72

8.4

9.7

—

Triptan medication for migraine, single purchase ok

133

0.66

0.72

8.4

9.7

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

138

1.39

0.71

11.1

8.4

—

Deviated nasal septum

1.62

0.71

12.9

9.5

—

Other and unspecified polyneuropathies, also in other diseases

1.75

0.71

15.6

8.2

—

Covid-19 suspected case

1.75

0.71

4.7

9.3

—

Burns and corrosions

1.92

0.70

20.8

9.3

—

Chronic laryngitis and laryngotracheitis

1.92

0.70

7.6

8.8

—

Selective serotonin reuptake inhibitors

122

1.32

0.70

10.7

9.0

—

COPD related to multimorbidity

1.52

0.69

10.7

9.3

—

Functional dyspepsia

1.55

0.69

12.1

7.8

—

Substance abuse

117

1.43

0.69

10.2

11.1

—

Other disorders of bladder

1.85

0.68

12.8

8.9

—

Chronic pancreatitis

1.85

0.68

10.2

10.0

—

Acute pancreatitis

1.67

0.68

14.7

9.0

—

Acute pancreatitis (for exclusion)

1.67

0.68

14.7

8.3

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

1.65

0.68

8.6

9.7

—

Other arrhythmias

1.43

0.67

11.2

8.9

—

Disorders of the thyroid gland

137

1.32

0.67

7.9

9.8

—

Abnormal serum enzyme levels

1.64

0.67

9.3

11.1

—

Postmenopausal bleeding

1.69

0.67

8.8

5.6

—

Rheumatoid arthritis, including avohilmo

0.55

0.67

4.0

7.9

—

Car occupant injured in other and unspecified transport accidents

1.63

0.66

15.4

9.3

—

Other antidepressants

121

1.31

0.66

12.7

8.9

—

Paracetamol or NSAID medication

1.80

0.64

7.6

12.2

—

Unstable angina pectoris

1.54

0.64

11.1

8.2

—

Ischaemic Stroke, excluding all haemorrhages

100

1.40

0.64

11.3

8.0

—

Migraine with aura and triptan purchases

1.72

0.64

10.4

12.9

—

Bleeding

138

1.32

0.63

9.9

9.6

—

Intracranial trauma

1.39

0.63

13.9

8.6

—

Symptoms and signs involving the urinary system

136

1.33

0.62

9.5

9.7

—

Migraine with aura

1.63

0.62

9.1

8.8

—

Persons encountering health services in circumstances related to reproduction

0.63

0.61

10.4

9.8

—

Mycoses

1.59

0.61

15.2

8.3

—

Mucosal proctocolitis

1.67

0.61

7.8

9.0

—

Trigger finger

1.67

0.61

11.2

6.3

—

Caries of dentine, including avohilmo

1.35

0.61

8.6

9.5

—

Superficial injury of head

1.60

0.61

11.9

7.5

—

L04AX Other immunosuppressants

130

1.38

0.60

5.7

9.5

—

Open wound of head

114

1.40

0.60

13.4

9.2

—

Haemorrhage from respiratory passages

1.55

0.60

6.4

9.8

—

Normotensive glaucoma

0.00

0.60

0.0

12.1

—

Other peripheral vertigo

0.00

0.60

0.0

11.2

—

Diagnoses used for exclusion with ILD

1.57

0.60

5.8

9.3

—

Other retinal disorders

118

1.35

0.60

11.2

8.9

—

Menorrhagia

1.57

0.59

8.1

7.1

—

Sleep disorders

143

1.30

0.59

7.9

9.7

—

Pleural plaque

0.00

0.59

0.0

8.8

—

Hypothyroidism, other/unspecified

131

1.30

0.58

6.4

9.7

—

Infective dermatitis

0.00

0.58

0.0

10.1

—

LSIL lesion of the cervix uteri

0.00

0.58

0.0

7.8

—

Atopic dermatitis, strict definition with reimbursement

1.51

0.58

6.0

8.7

—

Mental and behavioural disorders due to psychoactive substance use

120

1.37

0.58

10.2

11.1

—

Alzheimer disease, including avohilmo

0.57

7.0

8.3

—

Exclusions for E4_PCOS_BROAD

1.67

0.56

5.2

9.3

—

Hyperparathyroidism

1.65

0.56

11.7

8.3

—

Early onset COPD

1.45

0.56

11.1

9.0

—

Disturbances of skin sensation

1.45

0.56

12.0

9.3

—

Injuries to the ankle and foot

135

1.33

0.55

9.9

9.7

—

Retinal breaks without detachment

1.62

0.55

4.8

6.9

—

Benign neoplasm: Rectum

1.62

0.55

13.7

8.8

—

Second line medication for Crohn's disease

133

1.35

0.54

5.7

9.7

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

1.58

0.54

5.0

9.1

—

Salpingitis and oophoritis

1.58

0.54

4.2

8.1

—

Constipation

143

1.28

0.54

10.5

9.2

—

Embedded and impacted teeth

1.57

0.54

13.5

13.9

—

Sensorineural hearing loss

123

1.30

0.54

7.4

8.8

—

Diseases of salivary glands

1.49

0.53

6.2

9.2

—

Contraceptive management

0.60

0.53

10.2

9.4

—

Artificial joint operation, meniscal resection

146

0.74

0.53

9.1

9.3

—

Glomerular diseases

1.54

0.53

15.5

8.7

—

Type 1 diabetes, wide definition, subgroup 1

1.54

0.53

16.5

11.7

—

Disorders of choroid and retina

136

1.29

0.53

10.4

9.3

—

Major coronary heart disease event

116

1.29

0.52

9.6

8.2

—

Colonic or urogenital fistula

1.43

0.52

20.0

7.7

—

COPD, hospital admissions

1.39

0.51

10.5

9.5

—

Postpartum hemorraghe, all women as controls

1.50

0.51

7.7

8.3

—

Chronic apical periodontitis

144

1.25

0.51

11.2

8.8

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

1.41

0.51

7.4

11.1

—

Other and unspecified disorders of vitreous body

1.40

0.51

5.4

8.8

—

Neurological diseases

102

1.28

0.50

10.1

9.4

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1.38

0.50

5.8

9.2

—

Glucagon-like peptide-1 (GLP-1) analogues

1.38

0.50

5.8

9.2

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

140

1.26

0.50

6.2

9.6

—

Benign neoplasm of colon, rectum, anus and anal canal

129

1.31

0.49

12.2

8.4

—

Behavioural syndromes associated with physiological disturbances and physical factors

145

1.26

0.49

7.9

9.7

—

Hypertensive Heart Disease

1.56

0.49

11.7

9.6

—

Insomnia

143

1.26

0.49

6.8

9.7

—

Aortic aneurysm

1.56

0.49

9.1

8.7

—

Other gastritis (incl. Duodenitis)

1.56

0.48

10.1

7.4

—

Viral and other specified intestinal infections, including avohilmo

1.53

0.48

15.0

8.8

—

Presence of cardiac and vascular implants and grafts

1.39

0.48

12.5

9.3

—

Sequelae with surgical and medical care as external cause

1.52

0.48

8.1

7.8

—

Benign neoplasm: Rectum, anus and anal canal

1.52

0.48

14.0

8.5

—

Gestational [pregnancy-induced] hypertension

1.52

0.48

5.0

9.3

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

150

1.25

0.47

9.1

9.6

—

Carbimazole or st.post thyroidectomy, condition for graves disease

1.49

0.47

7.4

8.4

—

Injuries to the head

160

1.22

0.47

12.3

8.7

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

111

0.70

0.46

8.6

—

Leiomyoma of uterus

1.33

0.46

10.2

6.8

—

Necrosis of pulp, including avohilmo

127

1.32

0.46

9.1

10.3

—

Herpesviral [herpes simplex] infections, including avohilmo

1.43

0.46

14.0

8.3

—

Hernia

144

1.25

0.46

8.1

9.8

—

Other functional intestinal disorders

1.37

0.46

10.5

8.4

—

Endometriosis

1.49

0.45

8.2

7.1

—

Systemic connective tissue disorders

1.43

0.45

2.5

8.5

—

Transport accidents

1.39

0.45

15.8

9.3

—

Conduction disorders

1.40

0.45

11.6

7.9

—

Polyneuropathies and other disorders of the peripheral nervous system

1.40

0.45

15.6

7.9

—

Cervicalgia

1.40

0.45

14.4

7.7

—

Injuries to the neck

1.40

0.45

16.3

9.1

—

Gastrointestinal diseases

1.37

0.44

10.3

8.6

—

Fenamates

1.62

0.43

16.4

9.0

—

Any dementia

0.65

0.43

8.0

8.8

—

Diseases of inner ear

123

0.70

0.43

5.8

8.7

—

Status post-ami

1.44

0.43

18.5

7.9

—

ILD, hospital admissions 1, main diag only

1.61

0.43

13.4

9.2

—

Abnormal findings on diagnostic imaging of other body structures

1.61

0.43

8.4

7.4

—

Open wound of lower leg

1.61

0.43

1.0

9.0

—

Percutaneous Coronary Intervention

111

1.26

0.42

10.0

7.8

—

Schizophrenia or delusion, excluding more controls

1.44

0.42

3.5

9.8

—

Cellulitis

1.43

0.42

11.8

8.8

—

Effects of foreign body entering through natural orifice

1.43

0.42

8.0

10.1

—

Coronary revascularization (ANGIO or CABG)

111

1.26

0.42

9.3

7.8

—

Endometriosis of ovary

1.57

0.42

9.4

7.1

—

Internal derangement of knee

1.43

0.42

8.7

8.8

—

Rosacea

1.56

0.42

8.6

8.5

—

Dermatophytosis

1.56

0.42

16.0

8.5

—

Colectomy operation

1.56

0.42

18.4

8.6

—

Other bacterial intestinal infections

1.56

0.42

19.2

6.4

—

In situ neoplasms

0.64

0.42

14.2

8.9

—

Psoriasis

1.43

0.41

7.8

8.4

—

Primary coxarthrosis, bilateral

1.38

0.41

4.5

9.1

—

Disorders of synovium and tendon

1.32

0.41

8.9

8.0

—

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

0.00

0.41

0.0

11.2

—

Thyrotoxicosis with toxic multinodular goitre

0.00

0.41

0.0

10.3

—

Varicose veins of other sites

0.00

0.41

0.0

10.3

—

Disorders of calcium metabolism

0.00

0.41

0.0

12.1

—

Other and unspecified glaucoma

0.00

0.41

0.0

9.7

—

Oral lichen planus, including avohilmo , including avohilmo

0.00

0.41

0.0

10.2

—

Demyelinating diseases of the central nervous system

0.00

0.41

0.0

10.0

—

Genitourinary diseases

1.34

0.41

8.9

9.6

—

Use of antiglaucoma preparations and miotics

0.00

0.41

0.0

10.9

—

Sicca syndrome [Sjögren]

0.00

0.41

0.0

10.6

—

Melanocytic naevi, other sites/unspecified

0.00

0.41

0.0

12.3

—

Other/unspecified enthesopathies, not elsewhere classified

0.00

0.41

0.0

7.4

—

Scoliosis

0.00

0.41

0.0

11.4

—

Disorders of conjunctiva

150

1.24

0.41

12.1

8.7

—

Other and unspecified tonsillitis

1.36

0.41

12.8

10.0

—

Disease of hard tissues of teeth, NOS

1.36

0.41

10.9

8.7

—

Vasomotor rhinitis (mode)

0.00

0.40

0.0

11.8

—

Presbyopia

0.00

0.40

0.0

9.6

—

Carcinoma in situ of skin

0.00

0.40

0.0

11.6

—

Nail disorders

0.00

0.40

0.0

9.9

—

Sequelae of injuries of lower limb

0.00

0.40

0.0

10.8

—

Vascular dementia

0.00

0.40

0.0

11.2

—

Other interstitial pulmonary diseases

1.47

0.40

13.4

9.4

—

Ulcerative colitis

1.33

0.40

8.4

9.1

—

Otosclerosis

0.00

0.40

0.0

13.0

—

Sequelae of injuries of upper limb

0.00

0.40

0.0

11.4

—

Carcinoma in situ of cervix uteri

0.00

0.40

0.0

9.2

—

Other superficial mycoses, including avohilmo

0.00

0.40

0.0

12.4

—

Personal history of other diseases and conditions

0.00

0.40

0.0

12.8

—

Other/unspecified dorsalgia

1.36

0.39

6.2

8.9

—

Senile cataract

1.27

0.39

11.2

8.2

—

ILD, hospital admissions

1.43

0.39

13.4

9.1

—

Interstitial lung disease

1.43

0.39

13.4

9.1

—

Interstitial lung disease endpoints

1.43

0.39

13.4

9.1

—

Congenital malformations, deformations and chromosomal abnormalities

117

1.30

0.39

8.3

9.8

—

Urolithiasis

1.41

0.39

12.0

9.2

—

Disorders of mineral metabolism

0.00

0.39

0.0

10.1

—

Infections of genitourinary tract in pregnancy

0.00

0.39

0.0

9.6

—

Dyspnoea

154

1.22

0.38

6.8

9.8

—

Unspecified haematuria

1.34

0.38

8.0

9.7

—

Lyme disease, including avohilmo

1.38

0.38

14.6

8.3

—

Lyme disease

1.38

0.38

14.6

8.4

—

Spirochaetal infections, other/unspecified, including avohilmo

1.38

0.38

14.6

8.4

—

Other spirochaetal diseases

1.38

0.38

14.6

8.4

—

Bacterial intestinal infections, IBD co-morbidities

1.39

0.38

19.2

7.5

—

L02BA Anti-estrogens

1.39

0.38

15.2

8.4

—

Diabetic nephropathy

1.37

0.37

15.8

8.3

—

Adhesive capsulitis of shoulder

1.35

0.37

9.6

7.2

—

Other symptoms and signs involving the digestive system and abdomen

1.35

0.37

16.8

6.3

—

Biological medication for rheuma

1.35

0.37

12.6

9.5

—

Benign lipomatous neoplasm

1.30

0.37

8.3

8.7

—

Other viral diseases, not elsewhere classified

1.35

0.37

6.6

9.6

—

Inflammatory bowel disease

1.39

0.36

8.9

9.6

—

Any dementia, excluding more controls

0.62

0.36

6.2

9.3

—

Degenerative diseases of the nervous system

0.63

0.36

7.0

8.8

—

Postpartum haemorrhage

1.46

0.36

7.7

7.9

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

120

1.28

0.36

10.2

8.4

—

Concussion

1.29

0.35

13.8

8.6

—

Endometriosis ASRM stages 3,4

1.43

0.35

8.0

9.0

—

Type 1 diabetes, wide definition

1.43

0.35

16.5

10.6

—

Reimbursement for rheumatic diseases

125

1.27

0.35

5.6

9.4

—

Disorders of parathyroid gland

1.38

0.34

11.7

8.1

—

Coronary atherosclerosis

1.25

0.34

12.9

7.7

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1.37

0.34

16.4

8.5

—

Complications predominantly related to the puerperium

1.36

0.34

11.3

9.3

—

Preterm labour and delivery

1.36

0.34

9.3

—

Other intervertebral disc disorders

118

1.21

0.34

10.8

9.3

—

Other spirochaetal diseases, including avohilmo

1.34

0.34

14.6

8.5

—

Cerebrovascular diseases

125

1.22

0.34

11.7

8.3

—

Peritonsillar abscess

1.33

0.33

13.3

10.4

—

Viral warts, including avohilmo

1.33

0.33

12.8

7.8

—

5-aminosalicylic acid

1.33

0.33

11.3

9.7

—

Other diseases of lip and oral mucosa

100

1.30

0.33

10.5

8.9

—

Emergency coronary revascularization (for ACS)

120

1.21

0.33

9.6

8.2

—

Fracture of forearm

114

1.26

0.33

8.4

9.3

—

Spondylolisthesis/Spondylolysis

1.30

0.33

12.3

8.1

—

Other bacterial intestinal infections, including avohilmo

1.30

0.33

16.7

6.1

—

Fracture of lumbar spine and pelvis

1.30

0.33

12.2

9.0

—

Carpal tunnel syndrome

118

1.25

0.32

8.1

7.9

—

Glucosamine medication

1.28

0.32

11.2

7.9

—

Unspecified mental disorder

1.32

0.32

7.7

11.0

—

False labour

1.36

0.32

12.4

6.0

—

Unspecific neurodegenerative disorder

0.71

0.31

7.9

8.9

—

Myalgia

1.35

0.31

10.1

8.2

—

Ventral hernia

1.32

0.30

6.0

8.5

—

Other viral diseases, not elsewhere classified, including avohilmo

1.29

0.30

5.0

9.7

—

Pulmonary heart disease, diseases of pulmonary circulation

1.33

0.30

4.7

9.2

—

Polyuria

1.27

0.30

12.3

9.4

—

Sleep disorders (combined)

139

1.16

0.29

7.5

10.3

—

Haemorrhage in early pregnancy

1.26

0.29

12.4

7.8

—

Stroke, including SAH

112

1.22

0.29

11.3

8.2

—

Other disorders of eyelid

101

0.75

0.29

8.6

—

Missing teeth due to accident, extraction or parodontitis

132

1.22

0.29

6.8

9.0

—

Speech therapy

1.23

0.29

15.1

8.1

—

Uterine polyps

1.30

0.28

5.5

6.4

—

COPD, hospital admission 2, with asthma infections

1.32

0.28

8.6

8.9

—

Triptan medication for migraine, min. 3 purchases

0.77

0.28

8.2

9.3

—

Presence of other functional implants

104

0.79

0.28

6.8

8.5

—

Disorders of sclera, cornea, iris and ciliary body

121

1.24

0.28

7.4

10.0

—

Kela-code for severe mental illness

1.32

0.28

6.9

11.0

—

Sleep apnoea

157

0.84

0.28

6.8

9.8

—

Tonsillectomy and adenotomy

0.75

0.28

17.2

8.9

—

Excessive, frequent and irregular menstruation

1.33

0.27

11.2

7.0

—

Open wound of wrist and hand

1.27

0.27

9.2

11.6

—

Disorders of vestibular function (Vertigo)

113

0.78

0.27

5.8

8.2

—

Delivery

1.29

0.27

12.3

6.0

—

GI-bleeding

1.23

0.27

9.1

8.9

—

Chronic rhinitis, nasopharyngitis and pharyngitis

1.23

0.27

3.4

10.7

—

Ovarian cyst

1.29

0.26

9.3

7.0

—

Other diseases of the digestive system

1.21

0.26

9.1

8.6

—

Shoulder lesions

106

1.19

0.26

7.5

8.4

—

Excessive earwax

136

1.20

0.25

12.6

9.2

—

Symptoms and signs involving speech and voice

0.67

0.25

9.6

8.1

—

Gonarthrosis

1.22

0.25

8.4

7.7

—

Lumbar disc prolapse

111

1.20

0.25

12.4

9.4

—

Haemorrhoids and perianal venous thrombosis

1.24

0.25

14.2

8.3

—

Gonarthrosis, primary, with knee surgery

116

0.80

0.25

5.4

8.8

—

Abnormalities of heart beat

1.29

0.25

6.2

9.9

—

Conjunctivitis (acute, non atopic), including avohilmo

141

1.16

0.25

11.4

9.0

—

Conjunctivitis

144

1.17

0.24

11.7

8.7

—

Urticaria and erythema

0.74

0.24

9.7

8.8

—

Disorders of lacrimal system

104

1.23

0.23

11.1

8.0

—

Delivery, wide proxy

1.29

0.23

9.5

4.9

—

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

130

1.19

0.23

7.9

10.1

—

Pain and other conditions associated with female genital organs and menstrual cycle

1.31

0.23

4.0

7.7

—

Corneal ulcer

1.32

0.23

5.0

8.1

—

Hypertrophy of breast in women and men

1.32

0.23

2.8

9.5

—

Other and unspecified nonorganic psychotic disorders

1.28

0.23

3.4

11.2

—

Myocardial infarction, with ST-elevation

1.28

0.23

13.4

9.2

—

Supervision of high-risk pregnancy

1.25

0.22

11.6

5.4

—

Polyarthrosis

1.25

0.22

5.6

7.1

—

Fracture of shoulder and upper arm

1.26

0.22

8.2

8.5

—

Cardiodefibrillation

1.26

0.21

11.5

9.3

—

Symptoms and signs involving the circulatory and respiratory systems

109

1.15

0.21

9.6

10.5

—

Care involving use of rehabilitation procedures

121

1.19

0.21

10.9

9.3

—

Stomatitis and related lesions

1.19

0.21

8.6

8.5

—

Traumatic subarachnoid haemorrhage

0.00

0.21

0.0

7.3

—

Traumatic amputation of wrist and hand

0.00

0.21

0.0

10.5

—

Melanoma in situ

0.00

0.21

0.0

10.9

—

Prepatellar bursitis

0.00

0.21

0.0

8.6

—

Suppurative and necrotic conditions of lower respiratory tract

0.00

0.21

0.0

11.6

—

Other specified/unspecified systemic involvement of connective tissue

0.00

0.21

0.0

13.5

—

Bullous disorders

0.00

0.21

0.0

8.9

—

Impotence

0.00

0.21

0.0

10.3

—

Inflammatory disease of cervix uteri

0.00

0.21

0.0

9.3

—

Inflammatory disorders of breast

0.00

0.21

0.0

11.2

—

Other osteochondropathies

0.00

0.21

0.0

9.9

—

Contact with other sharp object(s)

0.00

0.21

0.0

12.5

—

Visual impairment including blindness (binocular or monocular)

0.00

0.21

0.0

12.3

—

Viral infections of the central nervous system

0.00

0.21

0.0

10.3

—

Heterophoria

0.00

0.21

0.0

12.4

—

Other puerperal infections

0.00

0.21

0.0

9.1

—

Abnormal findings on antenatal screening of mother

0.00

0.21

0.0

10.0

—

Intracranial injury

117

1.19

0.21

13.3

9.1

—

L02BX Other hormone antagonists and related agents

0.00

0.21

0.0

9.6

—

Other secondary gonarthrosis

0.00

0.21

0.0

13.6

—

Cerebral cysts

0.00

0.21

0.0

6.6

—

Trigeminal neuralgia

0.00

0.21

0.0

6.2

—

Dermatographic urticaria

0.00

0.21

0.0

10.8

—

MS-disease / Multiple Sclerosis

0.00

0.21

0.0

10.3

—

Viral infections of the central nervous system, including avohilmo

0.00

0.21

0.0

11.0

—

Papulosquamous disorders

1.22

0.21

7.4

9.5

—

Transient ischemic attack

100

1.19

0.21

10.9

8.3

—

Barrett oesophagus

0.00

0.21

0.0

8.1

—

Unspecified abortion

0.00

0.21

0.0

6.0

—

Other and unspecified disorders of skin and subcutaneous tissue

0.00

0.21

0.0

11.8

—

Corns and callosities

0.00

0.21

0.0

9.8

—

Other otitis externa (chronic)

0.00

0.21

0.0

11.4

—

Pedestrian injured in transport accident

0.00

0.21

0.0

11.2

—

Tubulo-interstitial nephritis, not specified as acute or chronic

0.00

0.21

0.0

11.8

—

Pilonidal cyst

0.00

0.21

0.0

9.7

—

Eating disorder

0.00

0.21

0.0

12.2

—

Major coronary heart disease event excluding revascularizations

1.18

0.20

9.7

8.0

—

Polycystic ovarian syndrome, consortium definition

1.17

0.20

8.3

7.4

—

Benign neoplasm: Choroid

0.00

0.20

0.0

12.1

—

Pleural plaque with presence of asbestos

0.00

0.20

0.0

10.1

—

Unknown and unspecified causes of morbidity

0.00

0.20

0.0

9.2

—

Allergic urticaria

0.00

0.20

0.0

12.4

—

Raynaud syndrome

0.00

0.20

0.0

11.0

—

Antepartum haemorrhage, not elsewhere classified

0.00

0.20

0.0

7.6

—

Use of pramipexole

1.20

0.19

11.0

7.6

—

Other and unspecified nerve root and plexus disorders, also in other diseases

1.18

0.19

13.7

7.0

—

Retinal detachments and breaks

1.23

0.18

5.1

8.6

—

Type 1 diabetes

1.13

0.18

16.5

10.8

—

Atopic dermatitis, strict definition

1.13

0.18

4.2

10.4

—

Other hearing loss

1.21

0.18

9.4

9.2

—

Benign neoplasm: Colon, unspecified

1.21

0.18

3.0

8.8

—

Irritable bowel syndrome

1.21

0.18

11.0

8.5

—

Seborrhoeic keratosis

1.19

0.18

3.9

8.4

—

Other menopausal disorders

1.15

0.18

14.4

6.5

—

Glaucoma

121

0.84

0.18

11.6

8.6

—

Presence of other devices

1.17

0.17

9.0

8.0

—

COPD, hospital admissions 1, only main diagnosis

1.23

0.17

12.4

9.4

—

Acute alcohol intoxication

1.15

0.17

8.4

9.7

—

Sequelae of external causes of morbidity and mortality

1.13

0.17

8.1

8.4

—

Episodal and paroxysmal disorders

137

1.11

0.17

11.7

9.5

—

Hallux valgus (acquired)

0.71

0.17

4.4

6.2

—

Diseases of the digestive system

100

1.19

0.17

11.7

9.0

—

Later onset COPD

1.19

0.17

8.6

10.8

—

Hernia of abdominal wall

101

1.19

0.16

6.8

9.3

—

Obesity due to excess calories

101

1.19

0.16

5.5

10.3

—

Other disorders of fluid, electrolyte and acid-base balance

1.16

0.16

12.4

9.4

—

Schizophrenia or delusion

1.16

0.16

3.5

10.7

—

Schizophrenia, schizotypal and delusional disorders

1.16

0.16

3.5

10.7

—

Type of accident

1.14

0.16

16.1

8.5

—

Infections with a predominantly sexual mode of transmission, including avohilmo

1.13

0.16

8.0

9.7

—

Noninflammatory disorders of female genital tract

1.13

0.15

7.9

7.0

—

Infections of the skin and subcutaneous tissue

128

1.15

0.15

11.7

9.9

—

Obesity related asthma

1.15

0.15

1.8

10.2

—

Osteopathies and chondropathies

128

0.86

0.15

7.7

8.9

—

Degeneration of macula and posterior pole

1.16

0.15

9.6

8.5

—

Disorders of lens

104

1.13

0.15

10.6

7.9

—

Rotator cuff syndrome

1.15

0.15

9.1

7.8

—

Medicines for HER+ breast cancer

1.10

0.15

10.2

7.2

—

Other maternal disorders predominantly related to pregnancy

0.85

0.14

13.1

7.8

—

Alcohol use disorder, ICD-based

1.18

0.14

7.8

10.3

—

Sleep apnoea, including avohilmo

154

1.10

0.14

7.6

9.9

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

129

0.88

0.14

8.0

9.2

—

Migraine

1.16

0.14

9.8

8.7

—

Diabetic retinopathy

0.80

0.14

17.8

7.5

—

Dementia

0.79

0.14

6.5

8.9

—

Single spontaneous delivery

1.19

0.13

9.9

6.0

—

Dementia, including avohilmo

0.83

0.13

5.9

9.2

—

Organic, including symptomatic, mental disorders

0.86

0.13

7.3

8.8

—

Other cataract

0.85

0.12

11.3

7.9

—

Diseases of external ear

1.18

0.12

11.4

8.7

—

Gonarthrosis [arthrosis of knee](FG)

1.12

0.12

9.9

8.6

—

Meniscus derangement

0.86

0.11

11.1

7.9

—

Other disorders of lacrimal gland

1.16

0.11

10.3

8.7

—

Medical abortion

0.88

0.10

9.9

7.6

—

Other noninflammatory disorders of uterus, except cervix

1.11

0.10

12.2

5.3

—

Lichen planus, including avohilmo

1.14

0.10

5.4

9.3

—

Myocardial infarction, unclassifiable

1.12

0.10

8.2

10.1

—

Iridocyclitis

1.11

0.09

13.4

7.6

—

Other strabismus

1.11

0.09

7.8

8.4

—

Chronic diseases of tonsils and adenoids

105

0.90

0.09

7.9

9.7

—

Nonsuppurative otitis media

1.08

0.09

1.0

11.6

—

Primary gonarthrosis, bilateral

113

0.89

0.09

4.5

8.6

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1.05

0.09

16.2

6.6

—

severe traumatic brain injury, does not include concussion

1.06

0.09

11.6

8.5

—

120

0.89

0.09

7.3

11.1

—

Propionic acid derivatives

1.08

0.09

8.0

11.8

—

Disorders of refraction and accommodation

1.11

0.09

17.2

8.7

—

Gonarthrosis,primary

137

0.92

0.09

9.0

8.6

—

Tinnitus

1.07

0.08

8.3

9.8

—

Pre-eclampsia or poor fetal growth

1.07

0.08

1.0

8.8

—

Polyp of the female genital tract

0.79

0.08

8.2

6.4

—

Allergic rhinitis

1.04

0.08

7.7

10.2

—

Gestational diabetes (for exclusion)

0.78

0.08

5.4

8.0

—

Diabetic retinopathy, excluding more controls

1.09

0.08

15.6

5.4

—

Other systemic involvement of connective tissue

0.82

0.08

4.2

8.0

—

Alcohol dependence

0.81

0.08

3.4

10.2

—

Rheumatoid arthritis

0.78

0.08

4.0

6.7

—

Umbilical hernia

0.78

0.08

7.8

9.1

—

Nonsuppurative otitis media, including avohilmo

1.10

0.08

1.0

10.7

—

Diseases of appendix

156

0.92

0.08

10.6

9.6

—

Calculus of kidney and ureter

1.04

0.08

14.9

9.3

—

Cholecystectomy

148

0.92

0.08

9.1

8.9

—

Pulmonary embolism

1.03

0.07

6.3

9.0

—

Epilepsy

0.85

0.07

14.3

9.5

—

Other enthesopathies

0.84

0.07

10.2

8.1

—

Persons with potential health hazards related to communicable diseases

0.83

0.07

11.0

9.5

—

Procreative management

1.08

0.07

12.8

9.3

—

Striking against or struck by other objects

1.06

0.07

5.9

10.8

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1.05

0.07

10.9

9.4

—

Sequelae of cerebrovascular disease

0.84

0.07

8.6

8.0

—

Pacemaker

0.84

0.07

13.6

8.5

—

Injury of muscle and tendon at shoulder and upper arm level

0.83

0.07

7.1

8.9

—

Persons encountering health services in other circumstances

0.82

0.07

12.0

10.1

—

Mouth breathing

0.82

0.07

4.9

9.9

—

Pregnancy hypertension

1.06

0.07

4.1

9.1

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

0.88

0.07

10.8

8.4

—

Keratitis

1.05

0.07

7.0

10.0

—

Extrapyramidal and movement disorders

1.03

0.07

15.0

8.3

—

Hyperlipidaemia, other/unspecified

0.88

0.06

7.9

9.9

—

Abrasion of teeth

1.12

0.06

12.5

8.8

—

Cholelithiasis, broad definition with cholecystitis

137

1.07

0.06

10.0

9.0

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

1.11

0.06

7.8

10.4

—

Appendicitis, broad definition

155

0.93

0.06

10.6

9.6

—

Dermatophytosis, including avohilmo

149

0.92

0.06

13.8

9.6

—

Dentofacial anomalies [including malocclusion]

131

1.07

0.06

13.4

8.8

—

Acute appendicitis

150

0.93

0.05

11.3

9.9

—

Benign neoplasm: Colon

121

1.09

0.05

10.5

8.7

—

Angina pectoris

1.08

0.05

14.3

7.6

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

106

1.09

0.05

12.0

10.6

—

Dental pulpitis, including avohilmo

140

1.05

0.04

9.6

9.9

—

Glaucoma suspect

1.10

0.04

12.3

8.6

—

Hypothyroidism, strict autoimmune

105

1.06

0.03

6.6

9.8

—

Mycoses, including avohilmo

167

1.05

0.03

12.5

8.9

—

Atopic dermatitis

104

1.07

0.03

6.6

10.4

—

Alcohol use disorder, Swedish definition

110

1.07

0.03

9.3

10.6

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

0.92

0.03

8.6

8.4

—

Fracture of lower leg, including ankle

119

1.07

0.03

5.2

9.5

—

Mental and behavioural disorders due to alcohol

107

1.07

0.02

7.3

10.8

—

Complications of labour and delivery

1.05

0.02

10.4

7.4

—

Other headache syndromes

1.07

0.01

12.0

8.7

—

Other arthrosis

0.94

0.01

6.1

7.6

—

Injuries to the shoulder and upper arm

159

0.97

0.00

9.3

9.7

—

Unspecified fall

111

0.97

0.00

9.8

—

Acute appendicitis, no complications

122

0.98

0.00

11.7

9.9

—

Appendectomy

140

1.02

0.00

10.9

9.4

—

Disorders of breast

1.05

0.00

5.7

8.0

—

Other symptoms and signs involving cognitive functions and awareness

0.98

0.00

8.8

9.3

—

Disorders of skin appendages

111

0.99

0.00

7.9

10.1

—

Varicose veins

111

1.02

0.00

7.9

8.3

—

Temporomandibular joint disorders, including avohilmo

1.02

0.00

12.5

8.5

—

Inguinal hernia

0.98

0.00

7.9

10.7

—

120

1.01

0.00

8.7

10.9

—

Pregnancy with abortive outcome

0.99

0.00

9.8

7.6

—

Cholelithiasis

136

1.00

0.00

8.6

8.9

—

Injuries to the wrist and hand

164

1.01

0.00

6.3

9.8

—

Chronic tubulo-interstitial nephritis

0.00

0.0

8.0

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

0.95

0.00

4.1

8.7

—

Volvulus

0.00

0.0

9.4

—

Convalescence

0.00

0.0

13.5

—

Other specified/unspecified inflammatory spondylopathies

0.00

0.0

11.3

—

Other and unspecified injuries of wrist and hand

0.00

0.0

9.0

—

Diffuse brain injury

0.00

0.0

6.9

—

Contusion of other and unspecified parts of foot

0.00

0.0

8.0

—

Deforming dorsopathies

0.95

0.00

12.3

8.2

—

Other disorders of veins

0.97

0.00

12.1

8.2

—

Fibroblastic disorders

0.98

0.00

16.2

8.0

—

Infections of breast associated with childbirth

0.00

0.0

2.4

—

Dementia due to Parkinsons disease, excluding more controls

0.00

0.0

9.5

—

Toxic effect of contact with venomous animals

0.00

0.0

11.0

—

Short Achilles tendon (acquired)

0.00

0.0

11.8

—

All dysplastic lesions of the vulva

0.00

0.0

10.6

—

Asthma mixed form (mode)

0.00

0.0

6.4

—

Herpesviral keratitis and keratoconjunctivitis

0.00

0.0

10.7

—

Other noninfective disorders of lymphatic vessels and lymph nodes

0.00

0.0

12.0

—

Impingement syndrome of shoulder

0.94

0.00

5.0

8.2

—

Sulfasalazine

0.92

0.00

5.0

9.8

—

Viral meningitis

0.00

0.0

8.0

—

Gonococcal infection

0.00

0.0

8.0

—

Maternal care for cervical incompetence

0.00

0.0

6.1

—

Female genital prolapse

0.93

-0.00

8.0

6.4

—

Emotional disorders and disorders of social functioning with onset specific to childhood

0.00

-0.00

0.0

9.0

—

Acetic acid derivatives and related substances

0.92

-0.00

4.0

11.8

—

Lichen simplex chronicus

0.00

-0.00

0.0

7.6

—

0.00

-0.00

0.0

8.0

—

L02BG Aromatase inhibitors

0.90

-0.00

8.8

7.0

—

Pleural plaque without asbestos

0.00

-0.00

0.0

11.3

—

0.93

-0.00

9.7

8.6

—

Female infertility

1.00

-0.00

4.8

7.6

—

Sulfonylureas

1.01

-0.00

6.1

9.7

—

Congenital deformities of feet, including avohilmo

0.00

-0.00

0.0

7.6

—

Sub-endpoint used in defining T1D endpoints

0.91

-0.00

16.5

10.1

—

Hypertrophic cardiomyopathy

0.00

-0.00

0.0

6.5

—

Other retinal artery occlusion

0.00

-0.00

0.0

11.6

—

Contact with sharp glass

0.00

-0.00

0.0

10.6

—

Enthesopathies of lower limb, excluding foot

0.91

-0.00

12.6

8.3

—

Other deformities of toe(s)

0.00

-0.00

0.0

10.0

—

Use of ropinirole

0.00

-0.00

0.0

8.9

—

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

0.00

-0.00

0.0

7.9

—

Melanocytic naevi of lower limb, including hip

0.00

-0.00

0.0

9.8

—

Failed induction of labour

0.00

-0.00

0.0

16.8

—

Hypercalcemia

0.00

-0.00

0.0

13.5

—

Benign neoplasm: Rectosigmoid junction

0.00

-0.00

0.0

9.0

—

Other benign neoplasms of skin

0.98

-0.00

12.1

8.4

—

Pregnancy, childbirth and the puerperium

0.90

-0.00

11.2

5.5

—

Actinic keratosis

0.97

-0.00

9.7

8.7

—

Carcinoma in situ of skin of trunk

0.00

-0.00

0.0

12.3

—

Sacroiliitis, not elsewhere classified

0.00

-0.00

0.0

6.6

—

Carcinoma in situ of skin of scalp and neck

0.00

-0.00

0.0

10.8

—

Carcinoma in situ of skin of upper limb, including shoulder

0.00

-0.00

0.0

10.2

—

Other endocrine disorders

0.00

-0.00

0.0

11.0

—

Crohn's disease of large intestine

0.00

-0.00

0.0

11.1

—

Other obstetric conditions, not elsewhere classified

1.02

-0.00

16.2

6.4

—

Alzheimer’s disease (Early onset), excluding more controls

0.00

-0.00

0.0

15.2

—

Sequelae of other and unspecified infectious and parasitic diseases

0.00

-0.00

0.0

10.4

—

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

0.00

-0.00

0.0

10.4

—

KRA_PSY_EATING, excluding more controls

0.00

-0.00

0.0

11.1

—

Vitamin deficiency

0.00

-0.00

0.0

10.4

—

Caught, crushed, jammed or pinched in or between objects

0.00

-0.00

0.0

13.7

—

Asthma mixed form (mode), excluding more controls

0.00

-0.00

0.0

7.1

—

Cervical disc disorders

0.95

-0.00

10.5

8.4

—

Status epilepticus

0.00

-0.00

0.0

6.5

—

Retention of urine

0.99

-0.00

12.3

10.1

—

Hypogonadotropic hypogonadism

0.00

-0.00

0.0

15.8

—

Generalized epilepsy

0.00

-0.00

0.0

7.6

—

Congenital malformations of eye, ear, face and neck

0.00

-0.00

0.0

10.6

—

Fitting and adjustment of other devices

1.01

-0.00

11.1

8.1

—

Other, unspecified and serous retinal detachments

0.00

-0.00

0.0

11.9

—

Secondary parkinsonism, excluding more controls

0.00

-0.00

0.0

10.0

—

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

0.00

-0.00

0.0

8.8

—

Cyst of Bartholin Gland

0.00

-0.00

0.0

6.8

—

Pneumonia due to Streptococcus pneumoniae

0.00

-0.00

0.0

9.0

—

Struck by thrown, projected or falling objec

0.00

-0.00

0.0

12.1

—

Desensitization to allergens

0.00

-0.00

0.0

9.8

—

Other obstetric trauma

0.00

-0.00

0.0

9.6

—

Other viral hepatitis

0.00

-0.00

0.0

10.4

—

Hypoparathyroidism

0.00

-0.00

0.0

13.3

—

Chondrocostal junction syndrome [Tietze]

0.00

-0.00

0.0

8.6

—

Vitamin deficiency, wide

0.00

-0.00

0.0

10.4

—

Chronic viral hepatitis

0.00

-0.00

0.0

11.3

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

0.93

-0.00

5.4

8.6

—

Neovascular glaucoma

0.00

-0.00

0.0

11.6

—

Separation of retinal layers (serosa)

0.00

-0.00

0.0

10.9

—

Other salmonella infections, including avohilmo

0.00

-0.00

0.0

9.1

—

IBD patients in KELA-register

0.96

-0.00

11.8

9.6

—

Inflammatory bowel disease, strict (require KELA)

0.94

-0.00

11.8

9.4

—

Skin changes due to chronic exposure to nonionizing radiation

0.96

-0.00

9.7

8.6

—

Sequelae of injuries, of poisoning and of other consequences of external causes

1.00

-0.00

26.0

8.5

—

therapeutic use

0.00

-0.00

0.0

11.7

—

Ingrowing nail

0.00

-0.00

0.0

10.1

—

Impacted maxillary molar

0.00

-0.00

0.0

10.2

—

Sequelae of other external causes

0.00

-0.00

0.0

13.2

—

Specific development disorders of speech and language

0.00

-0.00

0.0

9.8

—

Intussusception

0.00

-0.00

0.0

7.4

—

Family history of certain disabilities and chronic diseases leading to disablement

0.00

-0.00

0.0

9.3

—

Pyothorax

0.00

-0.00

0.0

14.0

—

Vascular dementia (subcortical)

0.00

-0.00

0.0

8.8

—

1.00

-0.00

7.0

8.5

—

Other intracranial haemorrhages

0.00

-0.00

0.0

6.6

—

Noise effects on inner ear

0.00

-0.00

0.0

14.0

—

Peripheral retinal degeneration

0.00

-0.00

0.0

7.6

—

Respiratory tuberculosis, not confirmed

0.00

-0.00

0.0

6.6

—

Other other unspecified disorders of the circulatory system

0.00

-0.00

0.0

9.8

—

Vasomotor and allergic rhinitis

0.95

-0.00

10.1

10.3

—

Chorioretinal inflammation

0.00

-0.00

0.0

10.0

—

Glaucoma secondary to other eye disorders

0.00

-0.00

0.0

12.8

—

Melanocytic naevi

0.97

-0.00

4.9

9.6

—

Other and unspecified corneal deformities and disorders

0.00

-0.00

0.0

7.6

—

Disorders of speech understanding and production

0.00

-0.00

0.0

9.0

—

Follow-up care involving plastic surgery

0.00

-0.00

0.0

12.0

—

Pulmonary heart disease

1.01

-0.00

6.3

8.8

—

Bulimia nervosa (incl. atypical)

0.00

-0.00

0.0

7.7

—

Other and unspecified degenerative diseases of nervous system

0.00

-0.00

0.0

11.6

—

Systemic atrophies primarily affecting the central nervous system

0.00

-0.00

0.0

10.4

—

Anankastic personality disorder

0.00

-0.00

0.0

6.5

—

Gonococcal infection, including avohilmo

0.00

-0.00

0.0

6.8

—

Other eating disorders

0.00

-0.00

0.0

10.4

—

Nonspecific lymphadenitis

0.00

-0.00

0.0

15.4

—

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

0.00

-0.00

0.0

9.0

—

Meralgia paraesthetica

0.00

-0.00

0.0

7.9

—

Secondary parkinsonism+Parkinsonism in other disease

0.00

-0.00

0.0

7.6

—

Labour and delivery complicated by umbilical cord complications

0.00

-0.00

0.0

6.9

—

Emotional disorders starting during childhood or adolescence

0.00

-0.00

0.0

9.0

—

Other systemic involvement of connective tissue (FG)

0.98

-0.00

4.2

7.3

—

Other specified disorders of kidney and ureter

0.00

-0.00

0.0

10.0

—

Other specified/unspecified dorsopathies

0.00

-0.00

0.0

11.8

—

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

0.00

-0.00

0.0

10.7

—

Vascular dementia (undefined)

0.00

-0.00

0.0

10.4

—

Viral meningitis, including avohilmo

0.00

-0.00

0.0

8.0

—

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

0.00

-0.00

0.0

14.1

—

Residual foreign body in soft tissue

0.00

-0.00

0.0

12.0

—

Oral lichen planus

0.00

-0.00

0.0

10.0

—

Chondromalacia

0.00

-0.00

0.0

7.6

—

Cutaneous abscess, furuncle and carbuncle

0.91

-0.00

13.3

8.8

—

Additional codes for the location of defect, injury or illness

0.00

-0.00

0.0

10.8

—

Other aneurysm

0.00

-0.00

0.0

9.6

—

Progressive vascular leukoencephalopathy

0.00

-0.00

0.0

5.4

—

Cramp and spasm

0.00

-0.00

0.0

9.0

—

Polycystic ovarian syndrome

0.00

-0.00

0.0

8.8

—

Gluteal tendinitis

0.00

-0.00

0.0

8.7

—

ILD-related respiratory insufficiency

0.00

-0.00

0.0

13.5

—

Other salmonella infections

0.00

-0.00

0.0

8.0

—

Medial epicondylitis

0.00

-0.00

0.0

11.4

—

Abnormal findings on diagnostic imaging of central nervous system

0.00

-0.00

0.0

9.0

—

Dissociative [conversion] disorders

0.00

-0.00

0.0

9.0

—

Recurrent dislocation of patella

0.00

-0.00

0.0

8.0

—

Other general symptoms and signs

0.00

-0.00

0.0

12.4

—

Use of biperiden

0.00

-0.00

0.0

9.5

—

Alzheimer’s disease (Early onset)

0.00

-0.00

0.0

7.7

—

Respiratory tuberculosis, not confirmed, including avohilmo

0.00

-0.00

0.0

6.6

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS